Negrao, M. V.; Araujo, H. A.; Lamberti, G.; Cooper, A. J.; Akhave, N. S.; Zhou, T.; Delasos, L.; Hicks, J. K.; Aldea, M.; Minuti, G.; Hines, J.; Aredo, J. V.; Dennis, M. J.; Chakrabarti, T.; Scott, S. C.; Bironzo, P.; Scheffler, M.; Christopoulos, P.; Stenzinger, A.; Riess, J. W.; Kim, S. Y.; Goldberg, S. B.; Li, M.; Wang, Q.; Qing, Y.; Ni, Y.; Do, M. T.; Lee, R.; Ricciuti, B.; Alessi, J. V.; Wang, J.; Resuli, B.; Landi, L.; Tseng, S. -C.; Nishino, M.; Digumarthy, S. R.; Rinsurongkawong, W.; Rinsurongkawong, V.; Vaporciyan, A. A.; Blumenschein, G. R.; Zhang, J.; Owen, D. H.; Blakely, C. M.; Mountzios, G.; Shu, C. A.; Bestvina, C. M.; Garassino, M. C.; Marrone, K. A.; Gray, J. E.; Patel, S. P.; Cummings, A. L.; Wakelee, H. A.; Wolf, J.; Scagliotti, G. V.; Cappuzzo, F.; Barlesi, F.; Patil, P. D.; Drusbosky, L.; Gibbons, D. L.; Meric-Bernstam, F.; Lee, J. J.; Heymach, J. V.; Hong, D. S.; Heist, R. S.; Awad, M. M.; Skoulidis, F., Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC, «CANCER DISCOVERY», 2023, 13, pp. 1556 - 1571 [Scientific article]Open Access
Elkrief A.; Alessi J.M.V.; Ricciuti B.; Brown S.; Rizvi H.; Preeshagul I.R.; Wang X.; Pecci F.; Di Federico A.; Lamberti G.; Egger J.V.; Chaft J.E.; Rudin C.M.; Riely G.J.; Kris M.G.; Ladanyi M.; Chen Y.; Hellmann M.D.; Shen R.; Awad M.M.; Schoenfeld A.J., Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study, «JOURNAL FOR IMMUNOTHERAPY OF CANCER», 2023, 11, Article number: e006994 , pp. 1 - 11 [Scientific article]Open Access
Stumpo S.; Formelli M.G.; Persano I.; Parlagreco E.; Lauricella E.; Rodriquenz M.G.; Guerrera L.P.; Zurlo I.V.; Campana D.; Brizzi M.P.; Cives M.; La Salvia A.; Lamberti G., Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives, «JOURNAL OF CLINICAL MEDICINE», 2023, 12, Article number: 7715 , pp. 1 - 25 [Scientific article]Open Access
Alessi J.V.; Wang X.; Elkrief A.; Ricciuti B.; Li Y.Y.; Gupta H.; Spurr L.F.; Rizvi H.; Luo J.; Pecci F.; Lamberti G.; Recondo G.; Venkatraman D.; Di Federico A.; Gandhi M.M.; Vaz V.R.; Nishino M.; Sholl L.M.; Cherniack A.D.; Ladanyi M.; Price A.; Richards A.L.; Donoghue M.; Lindsay J.; Sharma B.; Turner M.M.; Pfaff K.L.; Felt K.D.; Rodig S.J.; Lin X.; Meyerson M.L.; Johnson B.E.; Christiani D.C.; Schoenfeld A.J.; Awad M.M., Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and Immune Checkpoint Inhibitor Efficacy in NSCLC, «JOURNAL OF THORACIC ONCOLOGY», 2023, 18, pp. 1524 - 1537 [Scientific article]
Alessi J.V.; Ricciuti B.; Wang X.; Pecci F.; Di Federico A.; Lamberti G.; Elkrief A.; Rodig S.J.; Lebow E.S.; Eicholz J.E.; Thor M.; Rimner A.; Schoenfeld A.J.; Chaft J.E.; Johnson B.E.; Gomez D.R.; Awad M.M.; Shaverdian N., Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLC, «NATURE COMMUNICATIONS», 2023, 14, Article number: 4238 , pp. 1 - 12 [Scientific article]Open Access
Moliner, Laura; Zhang, Bingnan; Lamberti, Giuseppe; Ardizzoni, Andrea; Byers, Lauren A.; Califano, Raffaele, Novel therapeutic strategies for recurrent SCLC, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2023, 186, Article number: 104017 , pp. 1 - 9 [Scientific article]
Lamberti, Giuseppe; Andrini, Elisa; Ricci, Claudio; Campana, Davide, Omitting hemicolectomy for patients with appendiceal neuroendocrine tumours of 1-2 cm, «THE LANCET ONCOLOGY», 2023, 24, pp. e187 - e187 [Scientific article]
Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; Hellmann, M. D.; Kris, M. G.; Arcila, M. E.; Baine, M. K.; Rudin, C. M.; Lito, P.; Ladanyi, M.; Schoenfeld, A. J.; Riely, G. J.; Awad, M. M.; Arbour, K. C., Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12CMutant Non-Small Cell Lung Cancer, «THE ONCOLOGIST», 2023, 28, pp. 978 - 985 [Scientific article]Open Access
Rossi S.; Gelsomino F.; Rinaldi R.; Muccioli L.; Comito F.; Di Federico A.; De Giglio A.; Lamberti G.; Andrini E.; Mollica V.; D'Angelo R.; Baccari F.; Zenesini C.; Madia P.; Raschi E.; Cortelli P.; Ardizzoni A.; Guarino M., Peripheral nervous system adverse events associated with immune checkpoint inhibitors, «JOURNAL OF NEUROLOGY», 2023, 270, pp. 2975 - 2986 [Scientific article]Open Access
Nicole Brighi; Giuseppe Lamberti; Elisa Andrini; Cristina Mosconi; Lisa Manuzzi; Giada Donati; Andrea Lisotti; Davide Campana, Prospective Evaluation of MGMT-Promoter Methylation Status and Correlations with Outcomes to Temozolomide-Based Chemotherapy in Well-Differentiated Neuroendocrine Tumors, «CURRENT ONCOLOGY», 2023, 30, pp. 1381 - 1394 [Scientific article]Open Access
Di Federico A.; Ricciotti I.; Favorito V.; Michelina S.V.; Scaparone P.; Metro G.; De Giglio A.; Pecci F.; Lamberti G.; Ambrogio C.; Ricciuti B., Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer, «CURRENT ONCOLOGY REPORTS», 2023, 25, pp. 1017 - 1029 [Scientific article]
El Zarif, T.; Nassar, A. H.; Adib, E.; Fitzgerald, B. G.; Huang, J.; Mouhieddine, T. H.; Rubinstein, P. G.; Nonato, T.; Mckay, R. R.; Li, M.; Mittra, A.; Owen, D. H.; Baiocchi, R. A.; Lorentsen, M.; Dittus, C.; Dizman, N.; Falohun, A.; Abdel-Wahab, N.; Diab, A.; Bankapur, A.; Reed, A.; Kim, C.; Arora, A.; Shah, N. J.; El-Am, E.; Kozaily, E.; Abdallah, W.; Al-Hader, A.; Abu Ghazal, B.; Saeed, A.; Drolen, C.; Lechner, M. G.; Drakaki, A.; Baena, J.; Nebhan, C. A.; Haykal, T.; Morse, M. A.; Cortellini, A.; Pinato, D. J.; Dalla Pria, A.; Hall, E.; Bakalov, V.; Bahary, N.; Rajkumar, A.; Mangla, A.; Shah, V.; Singh, P.; Aboubakar Nana, F.; Lopetegui-Lia, N.; Dima, D.; Dobbs, R. W.; Funchain, P.; Saleem, R.; Woodford, R.; Long, G. V.; Menzies, A. M.; Genova, C.; Barletta, G.; Puri, S.; Florou, V.; Idossa, D.; Saponara, M.; Queirolo, P.; Lamberti, G.; Addeo, A.; Bersanelli, M.; Freeman, D.; Xie, W.; Reid, E. G.; Chiao, E. Y.; Sharon, E.; Johnson, D. B.; Ramaswami, R.; Bower, M.; Emu, B.; Marro, Safety and Activity of Immune Checkpoint Inhibitors in People Living with HIV and Cancer: A Real-World Report from the Cancer Therapy Using Checkpoint Inhibitors in People Living with HIV-International (CATCH-IT) Consortium, «JOURNAL OF CLINICAL ONCOLOGY», 2023, 41, pp. 3712 - 3723 [Scientific article]
Lamberti G.; Prinzi N.; Bongiovanni A.; Torniai M.; Andrini E.; Biase D.D.; Malvi D.; Mosca M.; Berardi R.; Ibrahim T.; Pusceddu S.; Campana D., Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET), «DIAGNOSTICS», 2023, 13, Article number: 1595 , pp. 1 - 12 [Scientific article]Open Access
Ricciuti B.; Elkrief A.; Alessi J.; Wang X.; Li Y.; Gupta H.; Muldoon D.M.; Bertram A.A.; Pecci F.; Lamberti G.; Di Federico A.; Barrichello A.; Vaz V.R.; Gandhi M.; Lee E.; Shapiro G.I.; Park H.; Nishino M.; Lindsay J.; Felt K.D.; Sharma B.; Cherniack A.D.; Rodig S.; Gomez D.R.; Shaverdian N.; Rakaee M.; Bandlamudi C.; Ladanyi M.; Janne P.A.; Schoenfeld A.J.; Sholl L.M.; Awad M.M.; Cheng M.L., Title: Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer, «CLINICAL CANCER RESEARCH», 2023, 29, pp. 2540 - 2550 [Scientific article]
Cortellini A.; Barrichello A.P.C.; Alessi J.V.; Ricciuti B.; Vaz V.R.; Newsom-Davis T.; Evans J.S.; Lamberti G.; Pecci F.; Viola P.; D'Alessio A.; Fulgenzi C.A.M.; Awad M.M.; Pinato D.J., A multicentre study of pembrolizumab time-of-day infusion patterns and clinical outcomes in non-small-cell lung cancer: too soon to promote morning infusions, «ANNALS OF ONCOLOGY», 2022, 33, pp. 1202 - 1204 [Comment or similar]
